id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-D-0133-0012,FDA,FDA-2007-D-0133,"Chronic Obstructive Pulmonary Disease: Developing Drugs for
Treatment Guidance for Industry",Other,Guidance,2016-05-25T04:00:00Z,2016,5,2016-05-25T04:00:00Z,,2024-11-07T23:42:55Z,,1,0,0900006481fefb63
FDA-2007-D-0133-0011,FDA,FDA-2007-D-0133,Chronic Obstructive Pulmonary Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2016-05-20T04:00:00Z,2016,5,2016-05-20T04:00:00Z,2016-07-20T03:59:59Z,2016-07-21T01:00:57Z,2016-11855,0,0,0900006481fe3c36
FDA-2007-D-0133-0003,FDA,FDA-2007-D-0133,Chronic Obstructive Pulmonary Disease: Developing Drugs for Treatment; Draft Guidance,Notice,NAD-Notice of Availability of Data,2008-05-16T04:00:00Z,2008,5,2008-05-16T04:00:00Z,,2008-05-16T23:12:25Z,,0,0,09000064805d9575
FDA-2007-D-0133-0002,FDA,FDA-2007-D-0133,Guidance for Industry Chronic Obstructive Pulmonary Disease: Developing Drugs for Treatment - Guidance Document,Other,GDL-Guidance (Supporting and Related Materials),2007-11-09T05:00:00Z,2007,11,,,2008-05-16T22:52:27Z,,0,0,090000648042a2c2
FDA-2007-D-0133-0001,FDA,FDA-2007-D-0133,See FDA-2007-D-0133-0003,Notice,,2007-11-09T00:00:00Z,2007,11,,,2008-05-28T00:54:44Z,,0,1,090000648042a2c0